Md. Mehadi Hasan Sohag

Mr. Md. Mehadi Hasan Sohag

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in The Open Microbiology Journal
Verified
Journal Article
Open access
PDF file
MBMahmudullah Bhuiya
Mahmudullah Bhuiya
KIKhairul Islam
Khairul Islam
MSMd. Mehadi Hasan Sohag
Md. Mehadi Hasan Sohag
HAHafij Ali
Hafij Ali
CRChapol K. Roy
Chapol K. Roy
ASAbu F. Sarker
Abu F. Sarker
Background: Pseudomonas aeruginosais a ubiquitous free-living bacterium and is responsible for severe nosocomial infections, life-threatening infections in immune compromised persons. The bacterium, along with its natural resistance, can acquire resistance to many antibiotics by a variety of methods.Method: Therefore, to compare the antibiotic sensitivity pattern ofPseudomonas aeruginosa, a total of seventeen isolates ofP. aeruginosawere isolated from different sources; for example environmental sources, frozen food sources, clinical sources and medical waste materials. Isolates were confirmed to beP. aeruginosaby cultural and biochemical properties.Result: The isolates were tested against seventeen commercially available antibiotics to observe the antibiotic susceptibility patterns. Imipenem and meropenem were the most potent antibiotics (100% sensitivity) followed by amikacin and piperacillin with maximum sensitivity. Among others, gentamicin, ciprofloxacin, levofloxacin and aztreonam were found to be fairly active. A good number of isolates were intermediately resistant to ceftriaxone. The rates of resistance to aztreonam, cefotaxime and ceftazidime were 11.76%, 82.35% and 5.88% respectively. Complete resistance was observed against penicillin, ampicillin, cefixime and cefpodoxime.Conclusion: It can be concluded that the clinical isolates including isolate from medical waste, were multi-drug resistant than environmental and food isolates indicating the risk of transmission of resistance to the environmental isolates ofP. aeruginosa.

30 June 2021 in Genomics & Informatics
Verified
Journal Article
Open access
PDF file
MSMd. Mehadi Hasan Sohag
Md. Mehadi Hasan Sohag
SRSaleh Muhammed Raqib
Saleh Muhammed Raqib
SASyaefudin Ali Akhmad
Syaefudin Ali Akhmad
Ranked in the topmost position among the deadliest diseases in the world, cardiovascular diseases (CVDs) are a global burden with alterations in heart and blood vessels. Early diagnostics and prognostics could be the best possible solution in CVD management. OMICS (genomics, proteomics, transcriptomics, and metabolomics) approaches which could be able to tackle the challenges against CVDs. Genome-wide association studies along with next-generation sequencing with various computational biology tools could lead a new sight in early detection and possible therapeutics of CVDs. Human cardiac proteins are also characterized by mass spectrophotometry could open the scope of proteomics approaches in CVD. Besides this, regulation of gene expression by transcriptomics approaches exhibits a new insight while metabolomics is the endpoint on the downstream of multi-omics approaches to confront CVDs from the early onset. Although a lot of challenges needed to overcome in CVD management, OMICS approaches are certainly a new prospect.

20 November 2018 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
AKAbir Khalil‐Mgharbel
Abir Khalil‐Mgharbel
HPHelena Polena
Helena Polena
PDPaul K. Dembélé
Paul K. Dembélé
MSMd. Mehadi Hasan Sohag
Md. Mehadi Hasan Sohag
JAJean‐Pierre Alcaraz
Jean‐Pierre Alcaraz
IVIsabelle Vilgrain
Isabelle Vilgrain

1 August 2015 in Food Science and Technology
Verified
Journal Article
Open access
PDF file
AKAbdul Kader
Abdul Kader
MDMitu Deb
Mitu Deb
AAAbdul Aziz
Abdul Aziz
MSMd. Mehadi Hasan Sohag
Md. Mehadi Hasan Sohag
SRSyeda Rumana Rahman
Syeda Rumana Rahman

9 December 2022 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
JAJahed Ahmed
Jahed Ahmed
ATAsma‐Ul‐ Taslim
Asma‐Ul‐ Taslim
TRTopu Raihan
Topu Raihan
MSMd. Mehadi Hasan Sohag
Md. Mehadi Hasan Sohag
MHMahmudul Hasan
Mahmudul Hasan
AAAbul Kalam Azad
Abul Kalam Azad

1 September 2025 in Plants
Verified
Journal Article
Open access
PDF file
Ponkti Addrita BosePonkti Addrita Bose
Ponkti Addrita Bose
MSMd. Mehadi Hasan Sohag
Md. Mehadi Hasan Sohag
Muhammad Fazle RabbeeMuhammad Fazle Rabbee
Muhammad Fazle Rabbee
TZTareque Muzahid Zamee
Tareque Muzahid Zamee
JKJab-Un-Nisha Kona
Jab-Un-Nisha Kona
Kwang-Hyun BaekKwang-Hyun Baek
Kwang-Hyun Baek
Gynura procumbens is a commonly adopted medicinal plant native to the tropical regions of East and Southeast Asia and is well recognized for its significant therapeutic potential. Traditionally used in herbal medicine, it has been employed to manage various conditions, including hypertension, diabetes, renal disorders, constipation, and inflammation. Its leaves are particularly rich in flavonoids—such as astragalin, kaempferol, quercetin, myricetin, and rutin—which are associated with anti-glycaemic, anticancer, antihypertensive, antimicrobial, and antioxidant activities. These bioactive constituents form the basis of the broad pharmacological profile of the plant. Emerging studies also suggest a potential role for G. procumbens in the management of infertility, further broadening its therapeutic scope. This review provides a concise overview of its phytochemical constituents, taxonomic classification, and current pharmacological evidence, highlighting its potential as a valuable candidate for novel drug development.